| For: | Wang L, Diao YZ, Ma XF, Luo YS, Guo QJ, Chen XQ. Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy. World J Gastrointest Surg 2024; 16(10): 3277-3287 [PMID: 39575283 DOI: 10.4240/wjgs.v16.i10.3277] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v16/i10/3277.htm |
| Number | Citing Articles |
| 1 |
Chunbaixue Yang, Jianchun Fan, Yixuan Zhang, Yixiao Zhang, Lei Xia, Xinran Cao, Xueliang Wu. Cellular characteristics of the immune microenvironment of colorectal cancer and progress in immunotherapy research. Annals of Medicine 2025; 57(1) doi: 10.1080/07853890.2025.2591308
|
| 2 |
Tatiana Sudarskikh, Kseniia Shalygina, Elena Shmakova, Pavel Iamshchikov, Alexey Dobrodeev, Irina Larionova, Julia Kzhyshkowska. Macrophages as predictors and new targets for immunotherapy in colorectal cancer. Exploration of Digestive Diseases 2026; 5 doi: 10.37349/edd.2026.1005124
|